<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Sun X</submitter><funding>Hospital-level Fund of Yueyang Integrated traditional Chinese and Western Medicine Hospital affiliated to Shanghai University of traditional Chinese Medicine</funding><funding>National Natural Science Foundation of China</funding><funding>National Key Research and Development Program of China</funding><funding>Shanghai Development Office of TCM</funding><pagination>299</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7106809</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>21(1)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Plaque psoriasis is a refractory inflammatory skin disease. The common therapies used to treat plaque psoriasis in traditional Chinese medicine (TCM) and western medicine (WM) have distinct characteristics and advantages. Although a combination of TCM and WM therapies, adjusted to the clinical situation, is widely used, there are no systematic studies on the hierarchical selection of this treatment combination based on the severity of skin lesions. We therefore designed a randomized clinical trial to focus on the sequence of internal and external treatments of TCM in patients with mild-to-moderate plaque psoriasis and to optimize the integration of Chinese and western medicine for the treatment of patients with severe plaque psoriasis, thereby achieving high-level clinic</pubmed_abstract><journal>Trials</journal><pubmed_title>Our Choice: study protocol for a randomized controlled trial for optimal implementation of psoriasis treatment by the integration of Chinese and western medicine.</pubmed_title><pmcid>PMC7106809</pmcid><funding_grant_id>81973860</funding_grant_id><funding_grant_id>2019YYQ31</funding_grant_id><funding_grant_id>81874470</funding_grant_id><funding_grant_id>ZY [2018-2020]-FWTX-1008</funding_grant_id><funding_grant_id>2018YFC1705304</funding_grant_id><funding_grant_id>ZY(2018-2020)-CCCX-2004-08</funding_grant_id><pubmed_authors>Liu L</pubmed_authors><pubmed_authors>Huang N</pubmed_authors><pubmed_authors>Guo S</pubmed_authors><pubmed_authors>Sun X</pubmed_authors><pubmed_authors>Zhou X</pubmed_authors><pubmed_authors>Wei Y</pubmed_authors><pubmed_authors>Yang C</pubmed_authors><pubmed_authors>Yang W</pubmed_authors><pubmed_authors>Li X</pubmed_authors><pubmed_authors>Ding X</pubmed_authors><pubmed_authors>Ding Y</pubmed_authors><pubmed_authors>Wang R</pubmed_authors><pubmed_authors>Zhang Y</pubmed_authors><pubmed_authors>Weng H</pubmed_authors><pubmed_authors>Yin Q</pubmed_authors><pubmed_authors>Chen X</pubmed_authors><pubmed_authors>Li B</pubmed_authors><pubmed_authors>Hu R</pubmed_authors></additional><is_claimable>false</is_claimable><name>Our Choice: study protocol for a randomized controlled trial for optimal implementation of psoriasis treatment by the integration of Chinese and western medicine.</name><description>&lt;h4>Background&lt;/h4>Plaque psoriasis is a refractory inflammatory skin disease. The common therapies used to treat plaque psoriasis in traditional Chinese medicine (TCM) and western medicine (WM) have distinct characteristics and advantages. Although a combination of TCM and WM therapies, adjusted to the clinical situation, is widely used, there are no systematic studies on the hierarchical selection of this treatment combination based on the severity of skin lesions. We therefore designed a randomized clinical trial to focus on the sequence of internal and external treatments of TCM in patients with mild-to-moderate plaque psoriasis and to optimize the integration of Chinese and western medicine for the treatment of patients with severe plaque psoriasis, thereby achieving high-level clinic</description><dates><release>2020-01-01T00:00:00Z</release><publication>2020 Mar</publication><modification>2026-05-03T18:55:16.466Z</modification><creation>2020-05-22T15:37:15Z</creation></dates><accession>S-EPMC7106809</accession><cross_references><pubmed>32228720</pubmed><doi>10.1186/s13063-020-4209-3</doi></cross_references></HashMap>